Skip to main content
Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
32.42
-0.14 (-0.43%)
Nov 20, 2024, 4:00 PM EST - Market closed

Immunocore Holdings Revenue

Immunocore Holdings had revenue of $80.25M in the quarter ending September 30, 2024, with 23.74% growth. This brings the company's revenue in the last twelve months to $296.31M, up 25.09% year-over-year. In the year 2023, Immunocore Holdings had annual revenue of $249.43M with 43.05% growth.

Revenue (ttm)
$296.31M
Revenue Growth
+25.09%
P/S Ratio
5.46
Revenue / Employee
$596,201
Employees
497
Market Cap
1.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023249.43M75.07M43.05%
Dec 31, 2022174.36M137.88M377.91%
Dec 31, 202136.48M6.37M21.15%
Dec 31, 202030.11M4.45M17.32%
Dec 31, 201925.67M2.02M8.52%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sep 30, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.59B
Clover Health Investments 2.12B
10x Genomics 629.74M
InMode 423.75M
Kiniksa Pharmaceuticals International, 384.10M
Dynavax Technologies 260.81M
Arvinas 161.10M
Nurix Therapeutics 56.42M
Revenue Rankings

IMCR News

More News